OticPharma Names New Chairman

Irvine-based OpticPharma, a biopharmaceuticals firm developing treatments for ear, nose, and throat (ENT) disorders, said today that it has named Keith A. Katkin as its Chairman of the board. Katkin is the President and CEO of Avanir Pharmaceuticals. Katkin also has served at Peninsula Pharmaceuticals, InterMune, Amgen and Abbott Laboratories. He is on the boards of Avanir, Rigel Therapeutics, Carbylan Therapeutics, and CoverMymeds, among other organizations.